Clinical trial
An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and Amphetamine-type Stimulant Dependence
NCT02541513 is registered in ClinicalTrials.gov with Universiti Sains Malaysia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and Amphetamine-type Stimulant Dependence
- Lead sponsor
- Universiti Sains Malaysia
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- May 31, 2013
- Completion date
- January 31, 2017
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
amphetamine dependence, heroin dependence